1-{3-hydroxybicyclo[1.1.1]pentan-1-yl}ethan-1-one, 97.0%, 10g

4-(1,2,4-Oxadiazol-3-yl)benzoic acid, 95%, 1g

1H-Pyrrolo[3,2-c]pyridine, 96.00%, 100g

2,4,6-TRI(9H-CARBAZOL-9-YL)-1,3,5-TRIAZINE, 95%, 1g

5-(2-Methylphenyl)cyclohexane-1,3-dione, 97.0%, 1g

(2E)-3-(2-nitrophenyl)-1-phenylprop-2-en-1-one, 97%, 10g

1-Methyl-3-n-octylimidazolium Bis(trifluoromethanesulfonyl)imide>97.0%(HPLC)25g

Tube filtrant Cartouches microfiltrantes, 2 (40 – 100 μm), 10 Pièce(s)

(S)-1-(2,6-dimethylphenyl)ethan-1-amine, 95%, 50mg

6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinolin-1(2H)-one, 95.0%, 500mg

Heptaethylene Glycol Monomethyl Ether>97.0%(GC)5g

Ethyl 2-Iodopropionate, 97% GC, 250mg

monoclonal de souris anti-plakoglobine, PG 5.1, 0,2 ml